Oliver Wyman Oliver Wyman
search
  • Global
    • Global (English)
  • Africa, India, Middle East
    • India (English)
    • Middle East (English)
    • South Africa (English)
  • Americas
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
  • Asia Pacific
    • China (中文版)
    • Japan (日本語)
    • Southeast Asia (English)
  • Europe
    • Belgium (English)
    • France (Français)
    • Germany (Deutsch)
    • Italy (Italiano)
    • Netherlands (English)
    • Nordics (English)
    • Portugal (Português)
    • Spain (Español)
    • Switzerland (Deutsch)
    • UK And Ireland (English)
Highlights
    Oliver Wyman
    • Global
      • Global (English)
      Africa, India, Middle East
      • India (English)
      • Middle East (English)
      • South Africa (English)
      Americas
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      Asia Pacific
      • China (中文版)
      • Japan (日本語)
      • Southeast Asia (English)
      Europe
      • Belgium (English)
      • France (Français)
      • Germany (Deutsch)
      • Italy (Italiano)
      • Netherlands (English)
      • Nordics (English)
      • Portugal (Português)
      • Spain (Español)
      • Switzerland (Deutsch)
      • UK And Ireland (English)
    • search
      Oliver Wyman
      Highlights
      • menu
        Oliver Wyman
        close
      Oliver Wyman
      Home  // . //  Oliver Wyman Health //  Infographic: Counter Overprescribing, Combat the Opioid Epidemic

      Infographic: Counter Overprescribing, Combat the Opioid Epidemic

      Using comparative data to curb overprescribing and control the opioid epidemic.

      Oliver Wyman Health

      1 min read

      Table of Contents

        Expand this image Share This Graphic

        View the infographic as a pdf here. 

        • Government Programs
        • Health and Life Sciences
        • Healthcare
        • Providers
        • Transformation
        Author
        • Oliver Wyman Health

        Biosimilar Makers Carve New Path Via Contracting, Partnering

        More than a year after losing exclusivity, Humira still holds a large market share. Biosimilar manufacturers are testing new contracting methods to catch up.

        In A Tight Economy, Purposeful Workforce Planning Is A Must

        Layoffs have continued in the biotech and pharma sector. To stem the tide, leadership teams need to make organizational and workforce effectiveness a priority.

        9 Trends Driving Historic ACA Enrollment Growth

        Several economic, public health, and health policy adjustments are leading to a record number of people signing up for Obamacare coverage.

        Healthcare Dealmaking Could Spike In 2025

        Dealmaking, cost containment, and emerging therapeutic areas took center stage at the 2025 J.P. Morgan Healthcare Conference.

        Marsh & McLennan logo

        Marsh McLennan is the leader in risk, strategy and people, helping clients navigate a dynamic environment through four global businesses.

        • Marsh logo
        • Guy Carpenter logo
        • Mercer logo
        • Oliver Wyman logo
        • Share
        • Terms Of Use
        • Privacy Notice
        • Cookie Notice
        • Statement On Accessibility
        • Manage Cookies
        • © 2025 Oliver Wyman, LLC. All Rights Reserved.